These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20664408)

  • 41. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
    Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.
    Ann Intern Med; 2005 Sep; 143(5):I47. PubMed ID: 16144889
    [No Abstract]   [Full Text] [Related]  

  • 43. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
    Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.
    Iodice S; Barile M; Rotmensz N; Feroce I; Bonanni B; Radice P; Bernard L; Maisonneuve P; Gandini S
    Eur J Cancer; 2010 Aug; 46(12):2275-84. PubMed ID: 20537530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations.
    Doren A; Vecchiola A; Aguirre B; Villaseca P
    Climacteric; 2018 Dec; 21(6):529-535. PubMed ID: 30295091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary Breast and ovarian cancer: providing personalized medicine.
    Tranin AS
    AWHONN Lifelines; 2005; 9(5):372-6. PubMed ID: 16359075
    [No Abstract]   [Full Text] [Related]  

  • 48. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.
    Infante M; Durán M; Acedo A; Pérez-Cabornero L; Sanz DJ; García-González M; Beristain E; Esteban-Cardeñosa E; de la Hoya M; Teulé A; Vega A; Tejada MI; Lastra E; Miner C; Velasco EA
    Clin Genet; 2010 Jan; 77(1):60-9. PubMed ID: 19912264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM; Kataja V; Pirskanen M; Arffman A; Ristonmaa U; Vahteristo P; Ryynänen M; Heinonen S; Kosma VM; Mannermaa A
    Clin Genet; 2007 Oct; 72(4):311-20. PubMed ID: 17850627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation and management of women with BRCA1/2 mutations.
    Peshkin BN; Isaacs C
    Oncology (Williston Park); 2005 Oct; 19(11):1451-9; discussion 1459-68 1474. PubMed ID: 16370446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.
    Hoskins PJ; Gotlieb WH
    CA Cancer J Clin; 2017 Nov; 67(6):493-506. PubMed ID: 28881380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries.
    Cherbal F; Bakour R; Adane S; Boualga K
    Breast Dis; 2012; 34(1):1-8. PubMed ID: 23697973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.
    Vidal-Millán S; Taja-Chayeb L; Gutiérrez-Hernández O; Ramírez Ugalde MT; Robles-Vidal C; Bargallo-Rocha E; Mohar-Betancourt A; Dueñas-González A
    Eur J Gynaecol Oncol; 2009; 30(5):527-30. PubMed ID: 19899408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer.
    Smirnova TY; Pospekhova NI; Lyubchenko LN; Tjulandin SA; Gar'kavtseva RF; Ginter EK; Karpukhin AV
    Bull Exp Biol Med; 2007 Jul; 144(1):83-5. PubMed ID: 18256760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosing ovarian cancer.
    Walker M; Sobel M
    CMAJ; 2018 Oct; 190(42):E1259. PubMed ID: 30348741
    [No Abstract]   [Full Text] [Related]  

  • 58. [Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia].
    Duarte F; Cameselle-Teijeiro JF; Soares R; Seixas C; Cortizo-Torres ME; Pérez-Villanueva J; Schmitt FC
    Rev Clin Esp; 2002 May; 202(5):259-63. PubMed ID: 12060539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.
    Esteves VF; Thuler LC; Amêndola LC; Koifman RJ; Koifman S; Frankel PP; Vieira RJ;
    Braz J Med Biol Res; 2009 May; 42(5):453-7. PubMed ID: 19377795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.
    Suthers GK
    ANZ J Surg; 2007 May; 77(5):314-9. PubMed ID: 17497966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.